Uveal melanoma (UM) is the most common eye cancer in adults which originates from pigmented cells in the uvea of the eye. The major challenge in UM treatment is the high fr...
The treatment of melanoma with checkpoint inhibitor (CPI) therapy has produced rapid and substantial gains in survival, and as a result, the indications for its use have st...
Uveal melanoma (UM) is a type of aggressive eye cancer that often spreads to the liver and has a poor prognosis. We don’t fully understand how UM spreads, which makes it ...
BC Pilot – James W. Smithy, MD, MHS
SMR Christopher J. Marshall Award – Sydney Shaffer, MD, PhD
SMR Young Investigator Award – Benjamin Izar, MD, PhD
MRF Endowed Merit Award (ASCO) – Piyush Grover, MBBS, B.Pharm
Apr 17, 2026 ET - Apr 19, 2026
